|
End-of-day quote
Shenzhen S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 8.810 CNY | -1.23% |
|
-4.24% | -27.49% |
| 08-20 | Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-22 | Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug | MT |
| Market Cap | 2.95B 443M 397M 365M 331M 619M 42.09B 630M 4.35B 1.75B 22.14B 1.66B 1.63B 69.82B | P/E 2024 |
79.5x | P/E 2025 | -63.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3.23B 485M 434M 399M 362M 676M 46.03B 689M 4.76B 1.91B 24.21B 1.82B 1.78B 76.36B | EV / Sales 2024 |
2.95x | EV / Sales 2025 | 3.69x |
| Free-Float |
42.98% | Yield 2024 |
1.57% | Yield 2025 | - |
| 1 day | -1.23% | ||
| 1 week | -4.24% | ||
| Current month | -20.13% | ||
| 1 month | -17.66% | ||
| 3 months | -15.85% | ||
| 6 months | -33.66% | ||
| Current year | -27.49% |
| 1 week | 8.64 |  | 9.65 |
| 1 month | 8.61 | | 12.51 |
| Current year | 8.61 | | 18.96 |
| 1 year | 8.61 | | 18.96 |
| 3 years | 6.81 | | 19.56 |
| 5 years | 6.81 | | 22.25 |
| 10 years | 6.81 | | 22.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Liu
CEO | Chief Executive Officer | 50 | 20/10/2018 |
Shen Hua Shi
DFI | Director of Finance/CFO | 63 | 15/04/2011 |
Chun Yan You
PRN | Corporate Officer/Principal | 50 | 17/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Xin Min Chen
CHM | Chairman | 60 | 20/10/2018 |
Zhi Jun Hua
CHM | Chairman | 57 | 15/04/2011 |
Jie Liu
BRD | Director/Board Member | 50 | 29/03/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.23% | -4.24% | -31.76% | -32.39% | 448M | |
| +3.85% | +11.57% | +68.24% | +151.14% | 1,224B | |
| +0.59% | +4.70% | +46.10% | +87.86% | 662B | |
| +1.84% | +3.83% | +29.96% | +109.02% | 514B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 388B | |
| +2.84% | +3.53% | +74.32% | +46.47% | 361B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 302B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 271B | |
| +2.30% | +7.09% | +61.10% | +78.74% | 249B | |
| +4.19% | +10.55% | +45.65% | +121.82% | 205B | |
| Average | +2.30% | +1.79% | +39.43% | +72.45% | 417.73B | |
| Weighted average by Cap. | +2.59% | +3.04% | +51.61% | +99.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.18B 178M 159M 146M 133M 248M 16.87B 253M 1.75B 701M 8.87B 667M 653M 27.98B | 1.18B 177M 158M 146M 132M 247M 16.78B 251M 1.74B 697M 8.83B 663M 649M 27.84B |
| Net income | 39.88M 5.99M 5.37M 4.94M 4.47M 8.36M 569M 8.52M 58.87M 23.63M 299M 22.49M 22.01M 944M | -63.47M -9.54M -8.54M -7.86M -7.12M -13.31M -905M -13.55M -93.69M -37.61M -476M -35.79M -35.03M -1.5B |
| Net Debt | 294M 44.17M 39.56M 36.38M 32.97M 61.62M 4.19B 62.78M 434M 174M 2.21B 166M 162M 6.96B | 276M 41.48M 37.15M 34.17M 30.96M 57.88M 3.94B 58.96M 408M 164M 2.07B 156M 152M 6.53B |
Employees
1,655
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | CN¥8.810 | -1.23% | 7,472,580 |
| 29/10/26 | CN¥8.920 | -1.65% | 5,457,651 |
| 28/10/26 | CN¥9.070 | +1.11% | 6,553,203 |
| 27/10/26 | CN¥8.970 | -3.76% | 7,732,300 |
| 26/10/26 | CN¥9.320 | +1.86% | 9,805,000 |
- Stock Market
- Stocks
- 002923 Stock
Select your edition
All financial news and data tailored to specific country editions
